BIOMAT Database Logo BIOMAT Database Logo

[Expression of EDAG-1 gene in human leukemia and lymphoma cell lines]. 2004

Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Department of Pathophysiology, Basic Medical College, Anhui Medical University, Hefei, Anhui 230 032, P.R. China.

OBJECTIVE Embryonic development associated gene 1 (EDAG-1), located at chromosome 9q22, is specially expressed in hematopoietic cells, and related to the regulation of hematopoietic system. This study was designed to explore relationship between pathogenesis of leukemia, lymphoma and EDAG-1 through analyzing the structure of EDAG-1 coding region, and its expression in these cell lines. METHODS Fifteen leukemia and lymphoma cell lines, HEL, K562, HL-60, Namalwa, Raji, J111, Jurkat, HuT 78, MEG-01, U937, 6T-CEM, HPB-ALL, KG-1a, THP-1, and DAMI, were selected to observe the expression of EDAG-1 by reverse transcriptase-polymerase chain reaction (RT-PCR), EDAG-1 cDNA coding fragments (1.5 kb) were purified to construct the corresponding recombinant plasmid. Then, the plasmid was sequenced to analyze mutation of the coding region. The expression of EDAG-1 protein, and mRNA in these cell lines were detected by Western blot, and Northern blot; the rearrangement and amplification of EDAG-1 genome in these cell lines were detected by Southern blot. RESULTS EDAG-1 mRNA and protein were highly expressed in erythroleukemia cell lines (K-562, HEL), megakaryoblast leukemia cell lines (DAMI, MEG-01), and T cell leukemia cell line (Jurkat), while no gene mutation was found in coding region, no amplification and rearrangement of genome was detected in these cell lines. EDAG-1 was absent in HL-60 cell line, and rearranged in HuT 78 cells. CONCLUSIONS EDAG-1 may relate with pathogenesis of erythroleukemia and megakaryoblast leukemia; its coding region may have no relation with the mechanism of its activation.

UI MeSH Term Description Entries
D007947 Leukemia, Megakaryoblastic, Acute An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common. Leukemia, Megakaryocytic,Leukemia, Megakaryocytic, Acute,Leukemia, Myeloid, Acute, M7,Megakaryoblastic Leukemia, Acute,Megakaryocytic Leukemia,Megakaryocytic Leukemia, Acute,Myeloid Leukemia, Acute, M7,Acute Megakaryoblastic Leukemia,Acute Megakaryoblastic Leukemias,Acute Megakaryocytic Leukemia,Acute Megakaryocytic Leukemias,Leukemia, Acute Megakaryoblastic,Leukemia, Acute Megakaryocytic,Leukemias, Acute Megakaryoblastic,Leukemias, Acute Megakaryocytic,Leukemias, Megakaryocytic,Megakaryoblastic Leukemias, Acute,Megakaryocytic Leukemias,Megakaryocytic Leukemias, Acute
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002899 Chromosomes, Human, Pair 9 A specific pair of GROUP C CHROMSOMES of the human chromosome classification. Chromosome 9
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic

Related Publications

Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Expression of the FLT3 gene in human leukemia-lymphoma cell lines.
May 1994, Leukemia,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
MDR1 expression in human leukemia-lymphoma cell lines.
June 1993, Leukemia,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Galectin-1 gene expression and methylation state in human T leukemia cell lines.
November 2000, International journal of oncology,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Expression and modulation of annexin VIII in human leukemia-lymphoma cell lines.
November 1993, Leukemia research,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Expression of the monocyte-specific esterase gene in leukemia-lymphoma cell lines.
January 1993, Leukemia,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
July 1998, Cancer letters,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Isoenzyme studies in human leukemia-lymphoma cell lines--1. Carboxylic esterase.
January 1985, Leukemia research,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Expression of caveolin-1 in human T cell leukemia cell lines.
December 1998, Biochemical and biophysical research communications,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Expression of protein kinase C subspecies in human leukemia-lymphoma cell lines.
April 1989, FEBS letters,
Ying Zhou, and Wang-Xiang Xu, and Yi-Qun Zhan, and Chang-Yan Li, and Cheng-Wang Xu, and Hong Zheng, and Fei-Fei Li, and Xiao-Ming Yang, and Si-Ying Wang
Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937.
January 2019, International journal of tryptophan research : IJTR,
Copied contents to your clipboard!